Evidence map›Paper›PMID 39876727›Full record

ArticleProceedings. Biological sciences2025

Estimation of end-of-outbreak probabilities in the presence of delayed and incomplete case reporting.

M J Plank, W S Hart, J Polonsky, M Keita, S Ahuka-Mundeke, R N Thompson

Abstract read
In one paragraph

Article in Proceedings. Biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M J PlankSchool of Mathematics and Statistics, University of Canterbury, Christchurch, New Zealand.ORCID 0000-0002-7539-3465
W S Hart *Mathematical Institute, University of Oxford, Oxford, UK.
J PolonskyGeneva Centre of Humanitarian Studies, University of Geneva, Geneva, Switzerland.
M KeitaWorld Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo.
S Ahuka-MundekeNational Institute of Biomedical Research, Kinshasa, Democratic Republic of Congo.
R N Thompson *Mathematical Institute, University of Oxford, Oxford, UK.ORCID 0000-0001-8545-5212

Funding

Engineering and Physical Sciences Research CouncilTe Niwha Infectious Diseases Research PlatformWorld Health Organization 001
6 · The paper itself

Abstract

Towards the end of an infectious disease outbreak, when a period has elapsed without new case notifications, a key question for public health policymakers is whether the outbreak can be declared over. This requires the benefits of a declaration (e.g. relaxation of outbreak control measures) to be balanced against the risk of a resurgence in cases. To support this decision-making, mathematical methods have been developed to quantify the end-of-outbreak probability. Here, we propose a new approach to this problem that accounts for a range of features of real-world outbreaks, specifically: (i) incomplete case ascertainment, (ii) reporting delays, (iii) individual heterogeneity in transmissibility and (iv) whether cases were imported or infected locally. We showcase our approach using two case studies: Covid-19 in New Zealand in 2020 and Ebola virus disease in the Democratic Republic of the Congo in 2018. In these examples, we found that the date when the estimated probability of no future infections reached 95% was relatively consistent across a range of modelling assumptions. This suggests that our modelling framework can generate robust quantitative estimates that can be used by policy advisors, alongside other sources of evidence, to inform end-of-outbreak declarations.

Indexed as

COVID-19Disease OutbreaksHemorrhagic Fever, EbolaDemocratic Republic of the CongoDisease NotificationHumansNew ZealandProbabilitySARS-CoV-2disease eliminationinfectious diseasesmathematical modellingstochastic model

Identifiers

PMID39876727
PMCPMC11775613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.